Start an analysis for OVV
Ovintiv Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $3.1bnEST | 30-Sep-26 | 10-Q filed 03-Nov-26 |
| Remaining authorization | Not found in filings | — | |
| Program expiry | 02-Oct-26 | 30-Sep-26 | 10-Q filed 03-Nov-26 |
| Repurchased last quarter | $386m | 30-Sep-26 | 10-Q filed 03-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 01-Oct-26 | $1.7bnEST 27.0m sh | Not found in filings | 04-Oct-27 | On October 1, 2026, Ovintiv announced it had received regulatory approval to purchase, for cancellation or return to treasury, up to approximately 27.0 million shares of common stock pursuant to a NCIB over a 12-month period from October 5, 2026, and ending October 4, 2027.10-Q filed 03-Nov-26 |
| 29-Sep-25 | $1.4bnEST 22.3m sh | $534mEST 8.4m sh left | 02-Oct-26 | On September 29, 2025, Ovintiv announced it had received regulatory approval to purchase, for cancellation or return to treasury, up to approximately 22.3 million shares of common stock pursuant to a NCIB over a 12-month period from October 3, 2025, and ending October 2, 2026.10-Q filed 03-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 1,659,544 | $62.76 | $104m | 10-Q filed 03-Nov-26 |
| 31-Aug-26 | 2,417,863 | $62.61 | $151m | 10-Q filed 03-Nov-26 |
| 31-Jul-26 | 2,255,144 | $57.71 | $130m | 10-Q filed 03-Nov-26 |
| 30-Jun-26 | 2,844,037 | $55.41 | $158m | 10-Q filed 23-Jul-26 |